Probing the Star Formation Main Sequence down to 10810^{8} M⊙_\odot at 1.0<z<3.01.0<z<3.0

We investigate the star formation main sequence (MS) (SFR-M$_{\star}$) down to 10$^{8-9}\mathrm{M}_\odot$ using a sample of 34,061 newly-discovered ultra-faint ($27\lesssim i \lesssim 30$ mag) galaxies at $1<z<3$ detected in the GOODS-N field. Virtually these galaxies are not contained in previous public catalogs, effectively doubling the number of known sources in the field. The sample was constructed by stacking the optical broad-band observations taken by the HST/GOODS-CANDELS surveys as well as the 25 ultra-deep medium-band images gathered by the GTC/SHARDS project. Our sources are faint (average observed magnitudes $\sim28.2$ mag, $\sim27.9$ mag), blue (UV-slope $\sim-1.9$), star-forming (rest-frame colors $\sim0.10$ mag, $\sim0.17$ mag) galaxies. These observational characteristics are identified with young (mass-weighted age $\sim0.014$ Gyr) stellar populations subject to low attenuations ($\sim0.30$ mag). Our sample allows us to probe the MS down to $10^{8.0}\,\mathrm{M}_\odot$ at $z=1$ and $10^{8.5}\,\mathrm{M}_\odot$ at $z=3$, around 0.6 dex deeper than previous analysis. In the low-mass galaxy regime, we find an average value for the slope of 0.97 at $1<z<2$ and 1.12 at $2<z<3$. Nearly $\sim$60% of our sample presents stellar masses in the range $10^{6-8}$ M$_\odot$ between $1<z<3$. If the slope of the MS remained constant in this regime, the sources populating the low-mass tail of our sample would qualify as starburst galaxies.Comment: 34 pages, 16 figures, 9 tables. Accepted for publication to Ap

Efficacy of a Strategy for Implementing Guidelines for the Control of Cardiovascular Risk in Primary Healthcare

Background: A number of strategies exist for the implementation of clinical practice guides (CPGs). Aim: To assess the efficacy of implementing a cardiovascular risk CPG based on an educational method involving opinion leaders, and the habitual method of dissemination among primary healthcare teams. Design and Setting: Controlled, blinded, community intervention trial randomised by clusters. Methods: 21 primary healthcare centres were randomly assigned to either the intervention arm (n = 11) or the control arm (n = 10). The study subjects were patients aged ≥45 years assigned to the centres. The overall impact of the intervention was measured as the difference between the increase in the proportion of patients whose medical records showed the recording of all the variables necessary to calculate cardiovascular risk in both arms. Analyses were performed with Generalized Lineal Model on an intention-to-treat basis. Results: 917 subjects were included at the beginning of the trial (437 in the intervention arm and 480 in the control arm). 826 subjects were included in the final evaluation (436 in the intervention group and 390 in the control arm). At the end of the trial, the recording of the variables necessary for the calculation of the cardiovascular risk in the intervention group had increased more than in the control group (difference between increases 7.49% (95% CI 4.62 - 10.35)) after adjusting for confounding variables. Conclusions: Compared to the habitual method of dissemination, the implementation of this CPG using an educational method involving opinion leaders, improved the recording of the variables needed to calculate patients’ cardiovascular risk.Funding for the trial was provided by the Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica (I+D+I). Instituto de Salud Carlos III—Fondo de Investigación Sanitaria. Expediente N˚ 031216.S

Propuestas para una reforma laboral democrática

Este trabajo, presenta trece propuestas complementarias sobre los temas centrales de la reforma laboral: la contracción individual y colectiva, con si variable de "subcontratación"; la transparencia con la proposición concreta de creación del registro nacional de contratos y sindicatos; los salarios y la jornada laboral, temas clave en el proyecto de país de la izquierda democrátic

SHARDS frontier fields: physical properties of a low-mass Lyα emitter at z = 5.75

We analyze the properties of a multiply-imaged Lyman-alpha (Lya) emitter at z=5.75 identified through SHARDS Frontier Fields intermediate-band imaging of the Hubble Frontier Fields (HFF) cluster Abell 370. The source, A370-L57, has low intrinsic luminosity (M_UV~-16.5), steep UV spectral index (\beta=-2.4+/-0.1), and extreme rest-frame equivalent width of Lya (EW(Lya)=420+180-120 \AA). Two different gravitational lens models predict high magnification (\mu~10--16) for the two detected counter-images, separated by 7", while a predicted third counter-image (\mu~3--4) is undetected. We find differences of ~50% in magnification between the two lens models, quantifying our current systematic uncertainties. Integral field spectroscopy of A370-L57 with MUSE shows a narrow (FWHM=204+/-10 km/s) and asymmetric Lya profile with an integrated luminosity L(Lya)~10^42 erg/s. The morphology in the HST bands comprises a compact clump (r_e<100 pc) that dominates the Lya and continuum emission and several fainter clumps at projected distances <1 kpc that coincide with an extension of the Lya emission in the SHARDS F823W17 and MUSE observations. The latter could be part of the same galaxy or an interacting companion. We find no evidence of contribution from AGN to the Lya emission. Fitting of the spectral energy distribution with stellar population models favors a very young (t<10 Myr), low mass (M*~10^6.5 Msun), and metal poor (Z<4x10^-3) stellar population. Its modest star formation rate (SFR~1.0 Msun/yr) implies high specific SFR (sSFR~2.5x10^-7 yr^-1) and SFR density (Sigma_SFR ~ 7-35 Msun/yr/kpc^2). The properties of A370-L57 make it a good representative of the population of galaxies responsible for cosmic reionization.Comment: 14 pages, 8 figures, 4 tables. Accepted for publication in Ap

Efficacy of a strategy for implementing a guideline for the control of cardiovascular risk in a primary healthcare setting: the SIRVA2 study a controlled, blinded community intervention trial randomised by clusters

This work describes the methodology used to assess a strategy for implementing clinical practice guidelines (CPG) for cardiovascular risk control in a health area of Madrid

Pauta per a l'avaluació de la contribució individual dels membres al procés grupal en el treball en equip universitari

Pauta desenvolupada en el marc del projecte "Millorar l'avaluació individualitzada dels projectes grupals mitjançant estratègies d'avaluació entre iguals i feedback", finançat en la convocatòria "Projectes de suport a la innovació docent 2017" de l'Oficina de Qualitat Docent de la UAB i coordinat per Aleix Barrera Corominas i Georgeta IonLa pauta que es presenta a continuació parteix d'un projecte que es fonamenta en la necessitat d'assegurar una avaluació més individualitzada quan el mètode de treball escollit pel professorat és el treball en equip. La pauta dissenyada permet una valoració individualitzada en context grupal, implicant els estudiants en el procés d'auto-avaluació i avaluació dels seus companys de grup

Estudio ROSA: validación de la versión española de la Relevant Outcome Scale for Alzheimer's Disease.

The Relevant Outcome Scale for Alzheimer's Disease (ROSA) is a useful tool for evaluating and monitoring dementia patients. This study aims to evaluate the validity and reliability of the Spanish version of ROSA. Spanish multicentre study involving 39 researchers and including 237 patients with Alzheimer disease (78 mild, 79 moderate, and 80 severe). The patients were tested with the following: Mini-Mental State Examination (MMSE), Fototest, Neuropsychiatric Inventory (NPI), Blessed dementia scale, and a Spanish-language version of ROSA. A subsample of 40 subjects was retested in the 14 days following the initial evaluation. The construct validity was evaluated with the Spearman correlation coefficient (r), internal consistency with Cronbach's alpha (alpha), and test-retest reliability with the intraclass correlation coefficient (ICC). ROSA requires 13.8±7.4minutes to administer and its results show a significant association with the clinical stage of AD (mild, 116.7±23.1; moderate, 92.9±19.8; and severe, 64.3±22.6), and with results on the MMSE (r=0.68), Fototest (r=0.63), NPI (r=0.53), and Blessed dementia scale (r=-0.80). ROSA shows high internal consistency (alpha=0.90) and excellent test-retest reliability (ICC0.97). The Spanish version of ROSA is a brief, valid, and reliable tool permitting overall evaluation of patients with dementia

Emission line galaxies in the SHARDS Frontier Fields - I. Candidate selection and the discovery of bursty Hα emitters

Emission line galaxies provide a crucial tool for the study of galaxy formation and evolution, providing a means to trace a galaxy's star formation history or metal enrichment, and to identify galaxies at a range of stellar masses. In this paper, we present a study of emission line galaxies in the Survey for High-z Absorption Red and Dead Sources (SHARDS) Frontier Fields (FF) medium-band survey. Through detailed flux calibrations we combine the first results of the SHARDS-FF survey with existing Hubble Frontier Field data to select 1098 candidate emission line galaxies from the Hubble Frontier Filed clusters Abell 370 and MACS J1149.5+2223. Furthermore, we implement this deep medium-band imaging to update photometric redshift estimates and stellar population parameters and discover 38 predominantly low-mass Hα emitters at redshifts 0.24 < z < 0.46. Overall, 27 of these sources have corresponding ultraviolet (UV) data from the Hubble Space Telescope that allow us to distinguish these sources and investigate the burstiness of their star formation histories. We find that more than 50 per cent of our sample shows an enhancement in Hα over UV, suggesting recent bursts in star formation on time-scales of a few to tens of Myr. We investigate these sources and find that they are typically low-mass discy galaxies with normal sizes. Their structures and star formation suggest that they are not undergoing mergers but are bursting due to alternative causes, such as gas accretion.This work was supported by the Science and Technology Facilities Council in the form of a studentship to AG. LF acknowledges funding from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001. DR-G thanks CONACYT for the research grant CB-A1-S-22784. This paper is (partly) based on SHARDS-FF data. SHARDS-FF is currently funded by Spanish Government grant PGC2018-093499-BI00. Based on observations made with the Gran Telescopio Canarias (GTC), installed at the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofísica de Canarias, in the island of La Palma. This work is also based partially on data and catalogue products from HFF-DeepSpace, funded by the National Science Foundation and Space Telescope Science Institute (operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555)

Etiopatogenia del prurito asociado a la enfermedad renal crónica: recomponiendo las piezas del puzle

Resumen: Definido como la sensación desagradable que provoca el deseo de rascarse, el prurito es el síntoma cutáneo más frecuente asociado a la uremia, pudiendo aparecer en casi la mitad de los pacientes con enfermedad renal crónica (ERC) avanzada. Más allá de su repercusión directa sobre la calidad de vida, el prurito asociado a la ERC (Pa-ERC) es un predictor independiente de mortalidad que además ejerce un efecto sinérgico con otros síntomas también relacionados con la calidad de vida, como la depresión y el insomnio. Aunque se han propuesto diferentes mecanismos para explicar su origen, la etiopatogenia del Pa-ERC sigue sin conocerse por completo. Dado que se han identificado nuevas dianas terapéuticas y recientemente varios ensayos clínicos han mostrado resultados prometedores, nuestra comprensión actual de las interrelaciones se ha ampliado significativamente, considerando multifactoriales los mecanismos fisiopatológicos subyacentes al Pa-ERC. En la presente revisión se discuten los potenciales factores desencadenantes de prurito en el paciente con ERC, incluyendo las hipótesis sobre la xerosis cutánea, el acúmulo de toxinas urémicas, la desregulación del sistema inmune y la inflamación sistémica, la neuropatía urémica y los desequilibrios en el sistema opioide endógeno, así como otras causas no urémicas de prurito, con el objetivo de orientar al clínico para realizar un adecuado abordaje etiopatogénico del Pa-ERC en su día a día. Abstract: Defined as the unpleasant sensation that causes the desire to scratch, pruritus is the most common skin symptom associated with uremia and appears in almost half of patients with advanced chronic kidney disease (CKD). Beyond its direct impact on quality of life, CKD-associated pruritus (CKD-aP) is an independent predictor of mortality that also has a synergistic effect with other quality of life-related symptoms, such as insomnia, depression, and anxiety. Although different mechanisms have been proposed to explain the origin of Pa-ERC, its etiopathogenesis is still not fully understood. Since new therapeutic targets have been identified and several clinical trials have recently shown promising results, our current understanding of the interrelationships has expanded significantly and the pathophysiological mechanisms underlying CKD-aP are now considered to be multifactorial. The potential triggers of pruritus in patients with CKD are discussed in this review, including hypotheses about skin xerosis, accumulation of uremic toxins, dysregulation of the immune system and systemic inflammation, uremic neuropathy, and imbalances in the endogenous opioid system. Other non-uremic causes of pruritus are also discussed, with the aim of guiding the physicians to apply an adequate etiopathogenic approach to CKD-aP in their day-to-day clinical practice

Educación para la salud en la escuela

La idea surge por las características de las ciudades dormitorio y por la conflictividad social en la que está inmerso el centro. Los objetivos son: descubrir y conocer el propio cuerpo, aplicar la Educación para la Salud en el aula, elaborar materiales y promover la participación de toda la comunidad educativa en la consecución de hábitos saludables. Los temas tratados en todas las etapas son: alimentación, higiene, medio ambiente, educación sexual, educación vial y prevención de drogodependencias. Colabora en el proyecto el centro de salud de la zona y monitores del Ayuntamiento, para la siembra de árboles y la educación vial. No adjunta memoria..Madrid (Comunidad Autónoma). Consejería de Sanidad y Servicios SocialesMadridNo disponibleES